295.97 0.00 (0.00%)
After hours: 5:13PM EST
|Bid||295.94 x 800|
|Ask||296.01 x 800|
|Day's Range||294.31 - 298.73|
|52 Week Range||208.34 - 306.00|
|Beta (3Y Monthly)||1.15|
|PE Ratio (TTM)||33.29|
|Earnings Date||Jan 28, 2020 - Feb 3, 2020|
|Forward Dividend & Yield||0.76 (0.26%)|
|1y Target Est||314.80|
Dentsply (XRAY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
DexCom's (DXCM) Q3 earnings benefit from higher revenues, solid performing Sensor and Transmitter segments and strong 2019 outlook. However, contraction in gross margin remains a woe.
Thermo Fisher Scientific Inc. announced Friday a new $2.5 billion stock repurchase program, with no expiration date. The analytical instruments and patient diagnostics company's new program replaces the current authorization, which had $500 million remaining. Based on Thursday's stock closing price of $293.54, the new program would allow for the repurchase of up to 8.5 million shares, or about 2.1% of the shares outstanding. The stock rose 0.3% in premarket trading. It has run up 31.2% year to date through Thursday, while the SPDR Health Care Select Sector ETF has gained 9.2% and the S&P 500 has rallied 23.1%.
WALTHAM, Mass. , Nov. 8, 2019 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its board of directors declared a quarterly cash dividend ...
Albeit Option Care Health (BIOS) is yet to reap material benefits from its merger-related synergies, the reporting of a positive gross margin in third-quarter results is encouraging for investors.
Cardinal Health (CAH) Q1 results benefit revenue growth and strong segmental performance. However, contraction in gross margin remains a concern.
Insulet's (PODD) year-over-year improvement in Q3 revenues on the solid uptake of Omnipod system both in the United States and across international markets looks promising.
Zacks.com featured highlights include: SYNNEX, Thermo Fisher Scientific, Allstate, Intel and Target